CUB Tri-Axis Dominant-Primary Series II-PR

Mentha × piperita

Peppermint

Tier IICUB Tri-Axis Dominant-Primary Series

Target Trait

1.52×

fold-change

Cooling-dominant tri-axis U+B modulated fold-change

Technical Specifications

SKU

SS-F-M3-01933

Genomic Edits

GC Content

46.8%

Construct Length

5,041 bp

Promoter System

Ubiquitin / T7

Expression System

Protoplast PEG-fusion

Host Strain

PEG-mediated

Receptor Target

TRPM8 + mGluR1 + TAS2R38 (suppression)

IFI Score

152

Pathway Edits

TRPM8 pathway primary gene cluster for cooling (IFI-C) tri-axis component
mGluR1 pathway primary gene cluster for umami (IFI-U) tri-axis component
TAS2R38 (suppression) pathway primary gene cluster for bitter-attenuation (IFI-B) tri-axis component
Tri-axis metabolic flux partitioning hub for concurrent CUB pathway operation
Cross-pathway regulatory circuit for cooling-dominant CUB triple-axis expression
Cofactor regeneration system (NADPH, ATP, acetyl-CoA) supporting triple-axis concurrent production

Key Interventions

Triple-axis receptor co-activation: TRPM8, mGluR1, and TAS2R38 (suppression) pathways simultaneously engineeredCooling-dominant tri-axis expression strategy (CUB) with cross-pathway flux managementPEG-mediated co-transfection of axis constructs for rapid phenotypic screening of multi-axis combinations

IFI Subscale Profile

IFI Profile

IFI-S

—

IFI-U

—

IFI-B

—

IFI-K

—

IFI-C

—

IFI-P

—

IFI-A

—

IFI-F

—

Use Case

Tier II CUB triple-axis construct for advanced multi-modal sensory architecture combining cooling, umami, and bitter-attenuation axes. Suitable for ultra-premium ingredient formulation requiring certification across three simultaneous IFI receptor pathways.

License

$699 · Tier II License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Multi-Axis · IFI-M All Modalities